Cyrus Biotechnology

📍 Seattle, United States🗓 Founded 2014👥 25 employees💰 Last funded Sep 2021
Biotechnology Research🌐 cyrusbio.com
Website LinkedIn
Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic. Cyrus is based on core software from the lab of David Baker at the University of Washington. We’ve worked with over 90 industry partners. We are based in Seattle, WA and financed by leading US and Asian Biotech and Tech investors including Orbimed, Trinity Ventures, Springrock, Agent Capital, iSelect, Yard Ventures, WRF and Alexandria. We are hiring! https://cyrusbio.com/careers/
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2014
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2015–2021 · investors recorded per year
201512017120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cyrus Biotechnology?
Cyrus Biotechnology has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Cyrus Biotechnology last raise funding?
The most recent investment in Cyrus Biotechnology recorded on gritt.io was in September 2021.
When was Cyrus Biotechnology founded?
Cyrus Biotechnology was founded in 2014.
What industry is Cyrus Biotechnology in?
Cyrus Biotechnology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cyrus Biotechnology based?
Cyrus Biotechnology is headquartered in Seattle, United States.